Bios Clinical Opportunity Fund, LP

Insider Reports History

Location
Fort Worth, TX
Signature
Bios Clinical Opportunity Fund, LP By: Bios Equity COF, LP, its general partner By: Bios Capital Management, LP, its general partner By: Bios Advisors, LLC, its general partner By: /s/ Aaron Glenn Louis Fletcher, Manager
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bios Clinical Opportunity Fund, LP:

Company Role Class Num Shares Value Price $ Report Date Ownership
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 500,095 $525,100 $1.05 08 Nov 2023 Direct
ACTUATE THERAPEUTICS, INC. 10%+ Owner Common Stock 84,917 12 Aug 2024 Directly held by BP Directors, LP
ACTUATE THERAPEUTICS, INC. 10%+ Owner Common Stock 69,375 12 Aug 2024 Directly held by Circle K Invesco, LP
ACTUATE THERAPEUTICS, INC. 10%+ Owner Common Stock 60,973 12 Aug 2024 Direct
ACTUATE THERAPEUTICS, INC. 10%+ Owner Common Stock 8,056 12 Aug 2024 Directly held by KF Legacy Trust U/A/D December 7, 2016
ACTUATE THERAPEUTICS, INC. 10%+ Owner Common Stock 8,056 12 Aug 2024 Directly held by MF Legacy Trust U/A/D December 7, 2016

Insider Reports Filed by Bios Clinical Opportunity Fund, LP

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACTU ACTUATE THERAPEUTICS, INC. 12 Aug 2024 0 $0 3 10%+ Owner 12 Aug 2024, 18:30
INAB IN8BIO, INC. 13 Dec 2023 0 $0 3 10%+ Owner 15 Dec 2023, 06:02
CGTX COGNITION THERAPEUTICS INC 08 Nov 2023 0 $0 3 Director, 10%+ Owner 13 Nov 2023, 17:17